2015
DOI: 10.1186/s12958-015-0064-6
|View full text |Cite
|
Sign up to set email alerts
|

Platelet concentrate in bovine reproduction: effects on in vitro embryo production and after intrauterine administration in repeat breeder cows

Abstract: BackgroundA repeat breeder cow (RBC) can be defined as an animal that after 3 or more inseminations cannot get pregnant because of fertilization failure or early embryonic death. If no cause is identified precisely, inadequate uterine receptivity is responsible for implantation failures. Since a large number of identified molecular mediators, such as cytokines, growth factors and lipids have been postulated to be involved in early feto-maternal interaction, in this study a different approach to the treatment o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
56
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 31 publications
(57 citation statements)
references
References 44 publications
1
56
0
Order By: Relevance
“…Considering the variability of the responses in superovulation and that none of the treatments are able to influence the recruitment process of small ovarian follicle turnover, the aim of this study was to stimulate the growth of small or preantral follicles by administrating platelet rich plasma (PRP) inside the ovary before the superovulation protocol. This hemocomponent is rich in growth factors and cytokines [16] known for their regenerative properties in human [17] and veterinary medicine [18,19]. Referring to human medicine, Sills et al [20] treated four women with proven infertility for 60 ± 25 months with 5 mL of autologous PRP for each ovary under ultrasound guidance via the transvaginal route.…”
Section: Introductionmentioning
confidence: 99%
“…Considering the variability of the responses in superovulation and that none of the treatments are able to influence the recruitment process of small ovarian follicle turnover, the aim of this study was to stimulate the growth of small or preantral follicles by administrating platelet rich plasma (PRP) inside the ovary before the superovulation protocol. This hemocomponent is rich in growth factors and cytokines [16] known for their regenerative properties in human [17] and veterinary medicine [18,19]. Referring to human medicine, Sills et al [20] treated four women with proven infertility for 60 ± 25 months with 5 mL of autologous PRP for each ovary under ultrasound guidance via the transvaginal route.…”
Section: Introductionmentioning
confidence: 99%
“…PRP-C produced with the method evaluated in the present study presented a slightly lower concentration of PLTs (947 × 10 3 PLTs/ μ L) when compared with the method described by Lange-Consiglio et al [11, 12] who achieved 1000 × 10 3 PLTs/ μ L. Furthermore, this same hemoderivative presented a lower concentration of PLTs when compared with the technique developed by Tsuzuki et al [13] who achieved 1528 × 10 3 PLTs/ μ L. On the other hand, the other PRP layers (A, B, and D) evaluated in the present study presented lower PLT concentrations in comparison with those obtained in the aforementioned studies [1113] and even in comparison to the PLT counts in whole blood of the same cows. Unfortunately, the WBC concentration was not reported for the techniques used for producing PRPs in cattle [11, 12, 29], which prevents us from comparing our findings with those reports.…”
Section: Discussionmentioning
confidence: 48%
“…Unfortunately, the WBC concentration was not reported for the techniques used for producing PRPs in cattle [11, 12, 29], which prevents us from comparing our findings with those reports.…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…The study by Anitua et al [12] used PRP that was either rich or poor in leucocytes in order to evaluate whether this could influence tissue healing; however, it appeared that leucocyte concentrations did not interfere with wound healing after oral surgery. Some issues were raised by Del Buono and colleagues [20] against the indiscriminate use of PRP or PRGF.…”
Section: Discussionmentioning
confidence: 99%